Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System

Abstract

Nearly half a century has passed since the discovery of cytoplasmic inheritance of human chloramphenicol resistance. The inheritance was then revealed to take place maternally by mitochondrial DNA (mtDNA). Later, a number of mutations in mtDNA were identified as a cause of severe inheritable metabolic diseases with neurological manifestation, and the impairment of mitochondrial functions has been probed in the pathogenesis of a wide range of illnesses including neurodegenerative diseases. Recently growing number of preclinical studies has revealed that animal behaviors are influenced by the impairment of mitochondrial functions and possibly by the loss of mitochondrial stress resilience. Indeed, as high as 54% of patients with one of the most common primary mitochondrial diseases, mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome, present psychiatric symptoms including cognitive impairment, mood disorder, anxiety, and psychosis. Mitochondria are multifunctional organelles which produce cellular energy and play a major role in other cellular functions including homeostasis, cellular signaling, and gene expression, among other. Mitochondrial functions are observed to be compromised and to become less resilient under continuous stress. Meanwhile, stress and inflammation have been linked to the activation of the tryptophan (Trp)-kynurenine (KYN) metabolic system, which observably contributes to development of pathological conditions including neurological and psychiatric disorders. This narrative review discusses the functions of mitochondria and the Trp-KYN system, the interaction of the Trp-KYN system with mitochondria, and the current understanding of the involvement of mitochondria and the Trp-KYN system in preclinical and clinical studies of major neurological and psychiatric diseases.

Translating neuroimaging changes to neuro-endophenotypes of autistic spectrum disorder: a narrative review

“…KYN is neuroprotective and evidence suggest its lower levels in neurodegenerative diseases and ASD. Growing evidence has revealed that mitochondria have a close link to KYN metabolism and that mitochondrial dysfunction and the activation of the KYN system contribute to the pathogenesis of neurodevelopmental disorders [134]. Thus, potential strategies of clinical neuroprotection using novel kynurenine metabolites and analogues could be a new approach toward treatment of ASD [135].…”

Play therapy in children with autism: Its role, implications, and limitations

“…Autism is a spectrum characterized by a wide range of persistent shortages in social interaction, impaired communication skills, restricted-repetitive forms of behavior, and the loss of social interests or activities. These social communication and interaction impairments may be due to impaired social signaling interpretation and failure to guide proper behaviors[ 6 ]. The exact mechanisms for these behavioral abnormalities are not yet defined.…”

Cognitive bias modification for adult’s depression: A systematic review and meta-analysis

“…Another study also showed that SSRIs are usually used as the first-line treatment for MDD. However, only 42-53% of patients treated with SSRIs have improved their condition, and medication for treatmentresistant depression remains a challenge (Tanaka et al, 2022). Biased cognition and maladaptive behavior patterns are considered to be the key factors leading to the development and persistence of depression.…”